<p>Westover Capital Advisors LLC 在最近向美國證券交易委員會（SEC）披露的信息中表示，在第二季度其在 Cardinal Health, Inc.（紐約證券交易所代碼：CAH - 免費報告）的持股增加了 75.8%。該基金在此期間購買了額外的 1,837 股後，持有該公司 4,262 股股票。截至其最近的 SEC 備案，Westover Capital Advisors LLC 在 Cardinal Health 的持股價值為 716,000 美元。</p>
<ul>
<li>懷疑市場？3 只股票應對恐懼、不確定性和懷疑</li>
</ul>
<p>其他對沖基金和機構投資者最近也對該公司的持倉進行了調整。Wellington Management Group LLP 在第一季度將其在 Cardinal Health 的股份增加了 1,666.7%。Wellington Management Group LLP 目前擁有 2,384,192 股該公司的股票，價值 328,470,000 美元，此前在上個季度購買了額外的 2,249,241 股。摩根大通（JPMorgan Chase &amp; Co.）在第一季度將其在 Cardinal Health 的股份增加了 40.0%。摩根大通目前擁有 4,175,992 股該公司的股票，價值 575,327,000 美元，此前在上個季度收購了額外的 1,193,983 股。瑞士再保險集團（Zurich Insurance Group Ltd FI）在第一季度將其在 Cardinal Health 的持股增加了 4,935.9%。瑞士再保險集團目前擁有 946,750 股該公司的股票，價值 130,434,000 美元，此前在上個季度收購了額外的 927,950 股。Acadian Asset Management LLC 在第二季度將其在 Cardinal Health 的持倉增加了 92.5%。Acadian Asset Management LLC 目前擁有 1,679,176 股該公司的股票，價值 282,063,000 美元，此前在上個季度購買了額外的 807,063 股。最後，Nuveen LLC 在第一季度購買了 Cardinal Health 的新頭寸，價值約 106,065,000 美元。對沖基金和其他機構投資者持有該公司 87.17% 的股票。</p>
<p>獲取 <strong>Cardinal Health</strong> 警報：</p>
<h2>分析師升級和降級</h2>
<p>CAH 最近成為幾份分析師報告的主題。摩根士丹利（Morgan Stanley）在 8 月 12 日的研究報告中重申了對 Cardinal Health 股票的 “增持” 評級。瑞穗（Mizuho）在 11 月 3 日的報告中將 Cardinal Health 股票的目標價從 170.00 美元上調至 210.00 美元，並給予公司 “跑贏大盤” 的評級。Evercore ISI 在 10 月 31 日的研究報告中將 Cardinal Health 股票的目標價從 190.00 美元上調至 220.00 美元，並給予公司 “跑贏大盤” 的評級。富國銀行（Wells Fargo &amp; Company）在 11 月 5 日的研究報告中將 Cardinal Health 的目標價從 185.00 美元上調至 221.00 美元，並給予公司 “增持” 評級。最後，Leerink Partners 在一份報告中將 Cardinal Health 的目標價從 211.00 美元上調至 230.00 美元，並給予該股票 “跑贏大盤” 的評級。十二位股票研究分析師對該股票給予了買入評級，兩位給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “適度買入”，共識目標價為 206.46 美元。</p>
<ul>
<li>醫療技術股票受益於急性護理需求上升</li>
</ul>
<p><strong>獲取我們最新的 CAH 股票分析</strong></p>
<h2>內部人士買賣</h2>
<p>在其他 Cardinal Health 的新聞中，首席執行官 Jason M. Hollar 於 8 月 20 日星期三出售了 35,901 股該股票。該股票的平均售價為 150.04 美元，總價值為 5,386,586.04 美元。交易後，首席執行官持有 200,000 股該公司的股票，價值約 30,008,000 美元。這代表了他們持股的 15.22% 的減少。該交易已在與證券交易委員會的法律文件中披露，可以通過 SEC 網站訪問。公司內部人士持有該公司 0.12% 的股票。</p>
<h2>Cardinal Health 股票上漲 0.4%</h2>
<ul>
<li>對於 Cardinal Health，證明將體現在其表現中</li>
</ul>
<p>CAH 週二開盤價為 206.25 美元。該股票的市值為 490 億美元，市盈率為 31.98，PEG 比率為 1.39，貝塔值為 0.72。該公司有 50 日移動平均價格為 166.70 美元，200 日移動平均價格為 159.64 美元。Cardinal Health, Inc. 的 12 個月低點為 114.60 美元，12 個月高點為 208.32 美元。</p>
<p>Cardinal Health（紐約證券交易所代碼：CAH - 獲取免費報告）最近於 10 月 30 日星期四發佈了其財報。該公司報告本季度每股收益（EPS）為 2.55 美元，超出分析師一致預期的 2.22 美元，超出 0.33 美元。該公司本季度的收入為 640.1 億美元，而一致預期為 594.1 億美元。Cardinal Health 的淨利潤率為 0.70%，股本回報率為負的 74.45%。該公司的收入同比增長 22.4%。在去年同期，該公司發佈的每股收益為 1.88 美元。Cardinal Health 已將其 2026 財年的指引設定為每股收益 9.650-9.850 美元。分析師預計 Cardinal Health, Inc. 本年度每股收益為 7.95 美元。</p>
<h2>Cardinal Health 宣佈分紅</h2>
<p>該公司最近還披露了一項季度分紅，將於 1 月 15 日星期四支付。記錄在案的投資者將在 1 月 2 日星期五獲得 0.5107 美元的分紅。該分紅的除息日為 1 月 2 日星期五。這代表了 2.04 美元的年化分紅和 1.0% 的分紅收益率。Cardinal Health 的派息比率目前為 30.77%。</p>
<h2>Cardinal Health 概況</h2>
<p>（免費報告）</p>
<p>Cardinal Health, Inc. 是一家在美國、加拿大、歐洲、亞洲及國際上運營的醫療服務和產品公司。它為醫院、醫療系統、藥房、門診手術中心、臨牀實驗室、醫生辦公室和家庭患者提供定製解決方案。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票，而非卡地納健康</li>
<li>消費者可選消費品股票解析</li>
<li>隨着人工智能推動存儲需求，希捷股票可能飆升</li>
<li>ETF 篩選器：用途及逐步指南</li>
<li>惠而浦的最壞情況可能已經過去——未來有上漲機會</li>
<li>即將到來的 IPO 股票鎖定期解析</li>
<li>這三隻被打壓的股票可能是你本季度最佳的購買機會</li>
</ul>
<p><strong>想知道其他對卡地納健康持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取卡地納健康公司（NYSE:CAH - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在卡地納健康嗎？</h2>
<p>在考慮卡地納健康之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而卡地納健康並不在名單上。</p>
<p>雖然卡地納健康目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

卡地納健康

<p>Westover Capital Advisors LLC 在第二季度將其在卡地納健康公司的持股增加了 75.8%，目前擁有 4,262 股，價值 716,000 美元。其他機構投資者也調整了他們的持倉，其中威靈頓管理公司、摩根大通和瑞士再保險的增持幅度顯著。分析師對卡地納健康給予了 “適度買入” 的評級，普遍目標價為 206.46 美元。該股票開盤價為 206.25 美元，市值為 490 億美元。最近的財報超出預期，收入同比增長 22.4%</p>

<p>Westover Capital Advisors LLC grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 75.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 4,262 shares of the company's stock after purchasing an additional 1,837 shares during the period. Westover Capital Advisors LLC's holdings in Cardinal Health were worth $716,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Westover Capital Advisors LLC 在最近向美國證券交易委員會（SEC）披露的信息中表示，在第二季度其在 Cardinal Health, Inc.（紐約證券交易所代碼：CAH - 免費報告）的持股增加了 75.8%。該基金在此期間購買了額外的 1,837 股後，持有該公司 4,262 股股票。截至其最近的 SEC 備案，Westover Capital Advisors LLC 在 Cardinal Health 的持股價值為 716,000 美元。</p>
</div><ul>
<li>Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt</li>
</ul>
<div class="lb-trans"><ul>
<li>懷疑市場？3 只股票應對恐懼、不確定性和懷疑</li>
</ul>
</div><p>Other hedge funds and other institutional investors also recently made changes to their positions in the company. Wellington Management Group LLP raised its stake in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after buying an additional 2,249,241 shares during the last quarter. JPMorgan Chase &amp; Co. grew its stake in shares of Cardinal Health by 40.0% in the first quarter. JPMorgan Chase &amp; Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after acquiring an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI increased its holdings in shares of Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company's stock valued at $130,434,000 after acquiring an additional 927,950 shares in the last quarter. Acadian Asset Management LLC raised its position in shares of Cardinal Health by 92.5% in the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company's stock worth $282,063,000 after purchasing an additional 807,063 shares during the last quarter. Finally, Nuveen LLC bought a new position in Cardinal Health in the 1st quarter worth about $106,065,000. Hedge funds and other institutional investors own 87.17% of the company's stock.</p>
<div class="lb-trans"><p>其他對沖基金和機構投資者最近也對該公司的持倉進行了調整。Wellington Management Group LLP 在第一季度將其在 Cardinal Health 的股份增加了 1,666.7%。Wellington Management Group LLP 目前擁有 2,384,192 股該公司的股票，價值 328,470,000 美元，此前在上個季度購買了額外的 2,249,241 股。摩根大通（JPMorgan Chase &amp; Co.）在第一季度將其在 Cardinal Health 的股份增加了 40.0%。摩根大通目前擁有 4,175,992 股該公司的股票，價值 575,327,000 美元，此前在上個季度收購了額外的 1,193,983 股。瑞士再保險集團（Zurich Insurance Group Ltd FI）在第一季度將其在 Cardinal Health 的持股增加了 4,935.9%。瑞士再保險集團目前擁有 946,750 股該公司的股票，價值 130,434,000 美元，此前在上個季度收購了額外的 927,950 股。Acadian Asset Management LLC 在第二季度將其在 Cardinal Health 的持倉增加了 92.5%。Acadian Asset Management LLC 目前擁有 1,679,176 股該公司的股票，價值 282,063,000 美元，此前在上個季度購買了額外的 807,063 股。最後，Nuveen LLC 在第一季度購買了 Cardinal Health 的新頭寸，價值約 106,065,000 美元。對沖基金和其他機構投資者持有該公司 87.17% 的股票。</p>
</div><p>Get <strong>Cardinal Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Cardinal Health</strong> 警報：</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><p>CAH has been the topic of several recent analyst reports. Morgan Stanley reissued an &#34;overweight&#34; rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Mizuho increased their price target on shares of Cardinal Health from $170.00 to $210.00 and gave the company an &#34;outperform&#34; rating in a report on Monday, November 3rd. Evercore ISI raised their price target on shares of Cardinal Health from $190.00 to $220.00 and gave the company an &#34;outperform&#34; rating in a research report on Friday, October 31st. Wells Fargo &amp; Company upped their price objective on Cardinal Health from $185.00 to $221.00 and gave the company an &#34;overweight&#34; rating in a research report on Wednesday, November 5th. Finally, Leerink Partners lifted their target price on Cardinal Health from $211.00 to $230.00 and gave the stock an &#34;outperform&#34; rating in a report on Monday. Twelve equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $206.46.</p>
<div class="lb-trans"><p>CAH 最近成為幾份分析師報告的主題。摩根士丹利（Morgan Stanley）在 8 月 12 日的研究報告中重申了對 Cardinal Health 股票的 “增持” 評級。瑞穗（Mizuho）在 11 月 3 日的報告中將 Cardinal Health 股票的目標價從 170.00 美元上調至 210.00 美元，並給予公司 “跑贏大盤” 的評級。Evercore ISI 在 10 月 31 日的研究報告中將 Cardinal Health 股票的目標價從 190.00 美元上調至 220.00 美元，並給予公司 “跑贏大盤” 的評級。富國銀行（Wells Fargo &amp; Company）在 11 月 5 日的研究報告中將 Cardinal Health 的目標價從 185.00 美元上調至 221.00 美元，並給予公司 “增持” 評級。最後，Leerink Partners 在一份報告中將 Cardinal Health 的目標價從 211.00 美元上調至 230.00 美元，並給予該股票 “跑贏大盤” 的評級。十二位股票研究分析師對該股票給予了買入評級，兩位給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的平均評級為 “適度買入”，共識目標價為 206.46 美元。</p>
</div><ul>
<li>Medical Technology Stock Benefits from Rising Acute Care Demand</li>
</ul>
<div class="lb-trans"><ul>
<li>醫療技術股票受益於急性護理需求上升</li>
</ul>
</div><p><strong>Get Our Latest Stock Analysis on CAH</strong></p>
<div class="lb-trans"><p><strong>獲取我們最新的 CAH 股票分析</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>內部人士買賣</h2>
</div><p>In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of the stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the transaction, the chief executive officer owned 200,000 shares of the company's stock, valued at approximately $30,008,000. This represents a 15.22% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.12% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Cardinal Health 的新聞中，首席執行官 Jason M. Hollar 於 8 月 20 日星期三出售了 35,901 股該股票。該股票的平均售價為 150.04 美元，總價值為 5,386,586.04 美元。交易後，首席執行官持有 200,000 股該公司的股票，價值約 30,008,000 美元。這代表了他們持股的 15.22% 的減少。該交易已在與證券交易委員會的法律文件中披露，可以通過 SEC 網站訪問。公司內部人士持有該公司 0.12% 的股票。</p>
</div><h2>Cardinal Health Stock Up 0.4%</h2>
<div class="lb-trans"><h2>Cardinal Health 股票上漲 0.4%</h2>
</div><ul>
<li>For Cardinal Health, the Proof Will be in Its Performance</li>
</ul>
<div class="lb-trans"><ul>
<li>對於 Cardinal Health，證明將體現在其表現中</li>
</ul>
</div><p>CAH opened at $206.25 on Tuesday. The stock has a market capitalization of $49.00 billion, a price-to-earnings ratio of 31.98, a PEG ratio of 1.39 and a beta of 0.72. The firm has a 50 day moving average price of $166.70 and a 200-day moving average price of $159.64. Cardinal Health, Inc. has a twelve month low of $114.60 and a twelve month high of $208.32.</p>
<div class="lb-trans"><p>CAH 週二開盤價為 206.25 美元。該股票的市值為 490 億美元，市盈率為 31.98，PEG 比率為 1.39，貝塔值為 0.72。該公司有 50 日移動平均價格為 166.70 美元，200 日移動平均價格為 159.64 美元。Cardinal Health, Inc. 的 12 個月低點為 114.60 美元，12 個月高點為 208.32 美元。</p>
</div><p>Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, topping analysts' consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion during the quarter, compared to the consensus estimate of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm's revenue was up 22.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.</p>
<div class="lb-trans"><p>Cardinal Health（紐約證券交易所代碼：CAH - 獲取免費報告）最近於 10 月 30 日星期四發佈了其財報。該公司報告本季度每股收益（EPS）為 2.55 美元，超出分析師一致預期的 2.22 美元，超出 0.33 美元。該公司本季度的收入為 640.1 億美元，而一致預期為 594.1 億美元。Cardinal Health 的淨利潤率為 0.70%，股本回報率為負的 74.45%。該公司的收入同比增長 22.4%。在去年同期，該公司發佈的每股收益為 1.88 美元。Cardinal Health 已將其 2026 財年的指引設定為每股收益 9.650-9.850 美元。分析師預計 Cardinal Health, Inc. 本年度每股收益為 7.95 美元。</p>
</div><h2>Cardinal Health Announces Dividend</h2>
<div class="lb-trans"><h2>Cardinal Health 宣佈分紅</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health's payout ratio is presently 30.77%.</p>
<div class="lb-trans"><p>該公司最近還披露了一項季度分紅，將於 1 月 15 日星期四支付。記錄在案的投資者將在 1 月 2 日星期五獲得 0.5107 美元的分紅。該分紅的除息日為 1 月 2 日星期五。這代表了 2.04 美元的年化分紅和 1.0% 的分紅收益率。Cardinal Health 的派息比率目前為 30.77%。</p>
</div><h2>Cardinal Health Profile</h2>
<div class="lb-trans"><h2>Cardinal Health 概況</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.</p>
<div class="lb-trans"><p>Cardinal Health, Inc. 是一家在美國、加拿大、歐洲、亞洲及國際上運營的醫療服務和產品公司。它為醫院、醫療系統、藥房、門診手術中心、臨牀實驗室、醫生辦公室和家庭患者提供定製解決方案。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Cardinal Health</li>
<li>Consumer Discretionary Stocks Explained</li>
<li>Seagate Stock Could Soar as AI Drives Storage Demand</li>
<li>ETF Screener: Uses and Step-by-Step Guide</li>
<li>Whirlpool’s Worst May Be Over—Upside Opportunity Ahead</li>
<li>Upcoming IPO Stock Lockup Period, Explained</li>
<li>These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而非卡地納健康</li>
<li>消費者可選消費品股票解析</li>
<li>隨着人工智能推動存儲需求，希捷股票可能飆升</li>
<li>ETF 篩選器：用途及逐步指南</li>
<li>惠而浦的最壞情況可能已經過去——未來有上漲機會</li>
<li>即將到來的 IPO 股票鎖定期解析</li>
<li>這三隻被打壓的股票可能是你本季度最佳的購買機會</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding CAH?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他對卡地納健康持有的對沖基金嗎？</strong> 訪問 HoldingsChannel.com 獲取卡地納健康公司（NYSE:CAH - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CAH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cardinal Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在卡地納健康嗎？</h2>
</div><p>Before you consider Cardinal Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮卡地納健康之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而卡地納健康並不在名單上。</p>
</div><p>While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然卡地納健康目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Westover Capital Advisors LLC 收購了卡地納健康公司（股票代碼：$CAH）的 1,837 股股票